Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A Modular Cross-Linker Platform for Proteome-Scale Mapping of Dynamic Protein-Protein Interactions in Cells

Award Number: R21AI200873
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 05/01/2026
PERIOD OF PERFORMANCE END DATE: 04/30/2028

Group Awards By:

View Award Description

A Modular Cross-Linker Platform for Proteome-Scale Mapping of Dynamic Protein-Protein Interactions in Cells - PROJECT SUMMARY Protein–protein interactions (PPIs) govern nearly every facet of cellular function and represent a key axis for therapeutic targeting. Yet, the vast majority of the ~650,000 predicted PPIs in the human proteome remain uncharacterized, largely due to limitations in technologies that can map interactions in live cells. Existing approaches rely on genetic tagging or in vitro systems and lack the resolution to detect transient, low-abundance, or state-specific interactions—especially in pharmacologically or disease-relevant contexts. This proposal aims to overcome these challenges by developing a next-generation crosslinking mass spectrometry (XL-MS) platform that enables quantitative, proteome-wide interactome mapping in live cells. Current XL-MS methods are limited by narrow residue reactivity, short and inflexible spacer geometries, inefficient enrichment strategies, and poor quantitative compatibility. Here, we will build a modular crosslinker platform that enables: (i) orthogonal residue reactivity and tunable spacer designs to access a broader spectrum of interaction interfaces; (ii) isotope-encoded handles for robust MS1-based quantitation; and (iii) cleavable enrichment handles that allow gentle, MS- compatible peptide recovery. In Aim 1, we will synthesize and benchmark a chemically diverse crosslinker library, systematically evaluating how spacer length, geometry, and residue reactivity affect proteome-wide PPI coverage in cells. In Aim 2, we will develop isotopically encoded variants and optimized workflows for quantitative PPI comparison across biological states, applying the platform to two high-impact systems: unbiased mapping of small molecule–modulated PPIs (stabilizers and disruptors) and dynamic PPI remodeling during human T cell activation. Together, these studies will establish a versatile XL-MS platform and reagents that addresses key limitations of current technologies, enabling quantitative, proteome-scale PPI discovery in native cellular contexts with unprecedented sensitivity, coverage, and versatility.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $230,000 )
2026	2026	SCRIPPS RESEARCH INSTITUTE	10550 N TORREY PINES RD	LA JOLLA	CA	92037	SAN DIEGO	USA	Allergy and Infectious Diseases Research	000	1	4/28/2026	NEW	$230,000
														Subtotal = $230,000

Grand Total All Awards = $230,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Modular Cross-Linker Platform for Proteome-Scale Mapping of Dynamic Protein-Protein Interactions in Cells

Award Number: R21AI200873

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 05/01/2026

PERIOD OF PERFORMANCE END DATE: 04/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer